Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Two Markman Victories..does .14 cents per share seem even remotely appropriate?
Let's be perfectly clear. The stock will appreciate on known dollars / dividends only ... This will not trade significantly higher on possibilities ... Not a chance in heck
Share
New Message
Please login to post a reply